Working… Menu

Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00469469
Recruitment Status : Withdrawn (unable to enroll subjects into the study)
First Posted : May 4, 2007
Last Update Posted : April 22, 2015
Genentech, Inc.
Information provided by:
Dartmouth-Hitchcock Medical Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Primary Completion Date : No date given
Estimated Study Completion Date : September 2009